摘要
目的 :探讨蝮蛇抗栓酶在治疗肺心病急性发作中的临床应用价值。方法 :采用蝮蛇抗栓酶联合其它综合措施治疗肺心病急性发作32例。结果 :蝮蛇抗栓酶组32例显效20例 ,有效9例 ,总有效率达90 6 % ;对照组总有效率仅达65 6 %。蝮蛇抗栓酶组疗效明显高于对照组(P<0 05)。结论
Objective: To study the therapeutic effect of Ahylysantinfarctase on acute episode of chronic cor pulmonale. Method: Using Ahylysantinfarctase with other therapeutic measures to treat 32 cases with acute episode of chronic cor pulmonale. Results: Of 32 cases treated by Ahylysantinfarctase, 20 cases show a prominent effect and 9 cases are better than before. The total effective rate reaches 90.6% in the test group (the group treated by Ahylysantinfarctase) while only 65.6% in the control group. The curative effect in the test group is much better than that in the control group (P<0.05). Conclusion: The application of Ahylysantinfarctase has provided an effective method for treating cor pulmonale.
出处
《大理医学院学报》
2000年第1期39-40,共2页
Journal of Dali Medical College
关键词
蝮蛇抗栓酶
肺心病
治疗
Ahylysantinfarctase
Cor pulmonale
Treatment